the challenge of relapse in transplant-eligible & transplant-ineligible patients with bdpcn
Published 1 year ago • 51 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:17
predictors of early relapse in transplant-eligible mm patients
-
2:16
phase i study of donor-derived γδ t cells as relapse prophylaxis post haplo/cy
-
2:50
conditioning intensity and genomics: relapse after allogeneic transplant in mds
-
2:19
how do we bridge to transplant in relapsed all?
-
11:05
the medical minute - ep. #16 - biopsy results
-
13:54
10-minute rounds: plasma exchange (replacement fluid)
-
1:01:29
hanna rennert - validation and implementation of whole-exome sequencing
-
0:42
challenges in treating patients with ras-pathway activating mutations in all
-
1:21
the remnant study: will treating patients at mrd relapse improve survival outcomes?
-
0:48
an overview of challenges that remain in the treatment of patients with al amyloidosis
-
2:56
overcoming challenges of ucb transplantation
-
1:30
the challenges of sudden donor changes
-
1:14
the challenges associated with treating patients with non-transfusion-dependent thalassemia
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
5:49
magnetismm-3 extended follow up results: elranatamab monotherapy in r/r multiple myeloma
-
3:49
the impact of allosct versus blood transfusion & iron chelation on the qol of patients with tdt
-
4:00
optimizing the outcomes of autohsct in multiple myeloma
-
2:53
triplet regimens for treating multiple myeloma at early relapse
-
0:56
real-world survival in patients with mixed phenotype attr-cm treated with tafamidis
-
57:25
transfusion decisions